EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pulse Biosciences's enterprise value is $1,023.54 Mil.
Pulse Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, Pulse Biosciences's EV-to-Revenue for today is .
The historical rank and industry rank for Pulse Biosciences's EV-to-Revenue or its related term are showing as below:
During the past 11 years, the highest EV-to-Revenue of Pulse Biosciences was 3319.14. The lowest was 17.20. And the median was 1063.75.
PLSE's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.12 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Pulse Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pulse Biosciences's EV-to-Revenue
For the Medical Instruments & Supplies subindustry, Pulse Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulse Biosciences's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pulse Biosciences's EV-to-Revenue falls into.
Pulse Biosciences's current Enterprise Value is $1,023.54 Mil.
Pulse Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulse Biosciences's share price for today is $16.89.
Pulse Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulse Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pulse Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLSE has been successfully added to your 